Cryopreserver Vitrafy has reported promising initial results from a follow-up blood platelet freezing trial with the US ...
From its first use in 1998, to its status as a routine management strategy when medication is not an option, our understanding of catheter ablation for AF has grown immensely 4. Over the past 28 years ...
Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results